Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
27.62
+1.08 (4.07%)
At close: Mar 9, 2026, 4:00 PM EDT
27.41
-0.21 (-0.76%)
After-hours: Mar 9, 2026, 7:45 PM EDT

Beam Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Market Capitalization
2,7432,7361,9742,1592,6925,327
Upgrade
Market Cap Growth
3.99%38.60%-8.58%-19.78%-49.47%15.54%
Upgrade
Enterprise Value
1,6501,8121,2101,3181,7764,539
Upgrade
Last Close Price
26.5427.7224.8027.2239.1179.69
Upgrade
PS Ratio
19.6119.5831.085.7244.18102.75
Upgrade
PB Ratio
2.132.212.692.203.676.44
Upgrade
P/TBV Ratio
2.212.212.692.203.676.44
Upgrade
P/OCF Ratio
----119.48-
Upgrade
EV/Sales Ratio
11.8112.9719.053.4929.1587.56
Upgrade
Debt / Equity Ratio
0.120.120.220.180.250.18
Upgrade
Net Debt / Equity Ratio
-0.88-0.88-0.94-1.04-1.22-0.99
Upgrade
Net Debt / EBITDA Ratio
3.023.021.756.502.773.56
Upgrade
Net Debt / FCF Ratio
3.033.031.945.5633.967.23
Upgrade
Asset Turnover
0.110.110.050.270.040.05
Upgrade
Quick Ratio
12.8512.854.675.794.825.93
Upgrade
Current Ratio
13.0913.094.825.894.895.96
Upgrade
Return on Equity (ROE)
-8.11%-8.11%-43.94%-15.46%-37.06%-69.13%
Upgrade
Return on Assets (ROA)
-18.55%-18.55%-20.26%-7.88%-15.02%-15.41%
Upgrade
Return on Capital Employed (ROCE)
-27.70%-27.70%-45.10%-14.10%-30.30%-18.80%
Upgrade
Earnings Yield
-2.92%-2.92%-19.09%-6.14%-10.74%-6.96%
Upgrade
FCF Yield
-13.14%-13.16%-18.05%-8.47%-0.98%-2.12%
Upgrade
Buyback Yield / Dilution
-20.16%-20.16%-6.69%-10.19%-9.01%-37.44%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.